| Literature DB >> 26135924 |
Vivek Phani Varma1, Lalitha Devi1, Naresh Kumar Venna1, Ch Lakshmi N Murthy1, Mohammed M Idris1, Sandeep Goel1.
Abstract
Cryostorage is of immense interest in biomedical research, especially for stem cell-based therapies and fertility preservation. Several protocols have been developed for efficient cryopreservation of cells and tissues, and a combination of dimethyl sulfoxide (DMSO) and fetal bovine serum (FBS) is commonly used. However, there is a need for an alternative to FBS because of ethical reasons, high cost, and risk of contamination with blood-borne diseases. The objective of the present study was to examine the possibility of using buffalo (Bubalus bubalis) ocular fluid (BuOF) to replace FBS in cryomedia. Frozen-thawed cells, which were cryopreserved in a cryomedia with BuOF, were assessed for viability, early and late apoptosis, and proliferation. Three cell lines (CHO, HEK, and C18-4), mouse embryonic stem (mES) cells, and primary cells, such as mouse embryonic fibroblast (MEF) cells, human peripheral blood mononuclear cells (hPBMCs), and mouse bone marrow cells (mBMCs), were cryopreserved in cryomedia containing 10% DMSO (D10) with 20% FBS (D10S20) or D10 with 20% BuOF (D10O20). For all three cell lines and mES cells cryopreserved in either D10S20 or D10O20, thawed cells showed no difference in cell viability or cell recovery. Western blot analysis of frozen-thawed-cultured cells revealed that the expression of Annexin V and proliferating cell nuclear antigen (PCNA) proteins, and the ratio of BAX/BCL2 proteins were similar in all three cell lines, mES cells, and hPBMCs cryopreserved in D10S20 and D10O20. However, initial cell viability, cell recovery after culture, and PCNA expression were significantly lower in MEF cells, and the BAX/BCL2 protein ratio was elevated in mBMCs cryopreserved in D10O20. Biochemical and proteomic analysis of BuOF showed the presence of several components that may have roles in imparting the cryoprotective property of BuOF. These results encourage further research to develop an efficient serum-free cryomedia for several cell types using BuOF.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26135924 PMCID: PMC4489643 DOI: 10.1371/journal.pone.0131291
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Comparative biochemical analysis of BuOF and FBS.
| Parameters (mg/dl) | Method used for analysis | BuOF | FBS | |
|---|---|---|---|---|
| 1 | Total Protein | Biuret | 0.5 ± 0.03 | 3.25 ± 0.23 |
| 2 | Albumin | Bromocresol green (BCG) | 0.2 ± 0.09 | 1.85 ± 0.32 |
| 3 | Globulin | Biuret and BCG | 0.3 ± 0.01 | 1.4 ± 0.2 |
| 4 | Lipoprotein A | Particle enhanced Immunoturbidimetry | 1.8 ± 0.1 | 2.5 ± 0.2 |
| 5 | Triglycerides | Glycerol-3-phosphate oxidase- phenol aminophenazone (GPO-PAP)colorimetry | 13 ± 0.9 | 61 ± 1.4 |
| 6 | Total Cholesterol | (Cholesterol oxidase- peroxidase enzyme) isotope dilution (CHO-POD) IDMS mass spectroscopy | 22.5 ± 1 | 27.5 ± 1.02 |
| 7 | LDL Cholesterol | Enzymatic immunoinhibition | 14 ± 0.9 | 8 ± 0.8 |
| 8 | HDL Cholesterol | (Total cholesterol)–(HDL + VLDL cholesterol) | 6 ± 0.7 | 8 ± 0.6 |
| 9 | VLDL Cholesterol | (TG /5) | 2.6 ± 0.5 | 12.5 ± 0.8 |
| 10 | Glucose | Hexokinase | 56.5 ± 2.3 | 77 ± 4.1 |
| 11 | Ascorbic acid | Spectrophotometry | 7.27 ± 0.7 | 1.13 ± 0.2 |
Values are represent in mean ± SEM.
Fig 1Cell viability and cell recovery in fresh and frozen–thawed cells.
(A) Cell viability of fresh and frozen-thawed cells as determined by trypan blue dye exclusion immediately after thawing. (B) Percentage of cell recovery of frozen–thawed cells after 24 h (MEF, C18-4, CHO, HEK, and mES cells) and 72 h (hPBMCs and mBMCs) of culture. (C) Cell viability as determined by trypan blue dye exclusion after 24 h (MEF, C18-4, CHO, HEK, and mES cells) and 72h (hPBMCs and mBMCs) of culture. Data represent mean ± SEM off our trials for each cell type in each group. Bars with different letters are significantly different at P < 0.05.
Fig 2Expression of proliferation-, pro-apoptosis-, anti-apoptosis-, and early apoptosis-specific proteins in frozen-thawed cells.
Expression of cell PCNA, BAX, BCL2, and Annexin V respectively in fresh and frozen–thawed cells after 24 h (MEF, C18-4, CHO, HEK, and mES cells) and 72 h (hPBMCs and mBMCs) of culture. Thirty-microgram aliquots of each cell extract were subjected to SDS-PAGE and western blot analysis. (A) Representative western blotting and densitometry analysis of (B) BAX/BCL2 ratio, (C) PCNA, and (D) Annexin V expression relative to GAPDH. Data represent mean ± SEM off our trials for a cell type in each group. Bars with different letters are significantly different at P < 0.05.
Proteomic analysis of BuOF and comparison with FBS.
| Name of the protein | Molecular weight (kDa) | Type of protein/role | Whether present or absent in FBS | |
|---|---|---|---|---|
| 1 | Apolipoprotein A-I precursor | 30.3 | High density lipoprotein/promotes proliferation and inhibits apoptosis of cells [ | Present |
| 2 | Fibronectin variable region | 20.4 | Glycoprotein/induces cell proliferation, inhibits apoptosis [ | Present |
| 3 | Transthyretin precursor | 15.7 | Thyroxine binding prealbumin | Present |
| 4 | Serum albumin | 53.9 | Globular protein/replaces serum in efficient cryopreservation of PBMCcells [ | Present |
| 5 | Alpha-1-B glycoprotein precursor | 53.5 | Glycoprotein | Present |
| 6 | Gelsolin | 80.7 | Lysophosphatidic acid transport protein/anti-oxidant properties [ | Present |
| 7 | Complement component 3 | 187.1 | Glycoprotein | Present |
| 8 | Keratin 5, type II | 62.6 | Cytoskeletal protein | Present |
| 9 | Inter-alpha-trypsin inhibitor heavy chain H2 precursor | 106.1 | Carrier protein | Present |
| 10 | Albumin | 69.2 | Globular protein/replace sserum in efficient cryopreservation of PBMC cells [ | Present |
| 11 | Complement factor B precursor | 85.3 | Circulatory protein | Present |
| 12 | Keratin 7, type II | 50 | Cytoskeletal protein | Present |
| 13 | Transferrin isoform X1 | 77.6 | Glycoprotein/major anti-oxidant protein andprotects spermatozoa against oxidative damage during freeze–thawstress [ | Present |
| 14 | Keratin 42, type 1 like isoform X3 | 50.3 | Cytoskeletal protein | Present |
| 15 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 isoform X1 | 46.1 | Enzyme/inhibit sapoptosis by inhibitingcaspase-3 [ | Present |
| 16 | Crystal structure of BSA chain b | 66.4 | Globular protein/replaces serum in efficient cryopreservation of PBMCcells [ | Present |
| 17 | Alpha-2-HS-glycoprotein precursor | 38.4 | Glycoprotein | Absent |
| 18 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 22.7 | Globulin glycoprotein/inhibits apoptosis by inhibiting caspase-3 [ | Absent |
| 19 | Regucalcin | 33.3 | Calcium binding protein/maintains cell homeostasis and playa role as a suppressor protein in cell signaling systems in many cell types [ | Absent |
| 20 | Crystal structure of bovine factor Vai, chain A | 34.7 | Inactivated form of factor Va | Absent |
| 21 | Endopin 2C | 46.7 | Type of serpin/inhibits cysteine proteases and elastase-like serine proteases therefore eventually inhibit apoptosis [ | Absent |
| 22 | Fetuin B precursor | 42.6 | Glycoprotein/anti-oxidant and helps maintain sperm morphology by increasing ROS scavenging enzymes [ | Absent |
| 23 | Fibrinogen alpha chain | 18.1 | Glycoprotein | Absent |
| 24 | Apolipoprotein E | 27.1 | Lipoprotein | Absent |
| 25 | C-type lectin domain family 3, member B precursor | 22.1 | Plasminogen binding protein | Absent |
| 26 | Adiponectin | 26.1 | Hormone(cytokine) | Absent |
| 27 | Transferrin precursor | 77.7 | Glycoprotein/major anti-oxidant protein andprotects spermatozoa against oxidative damage during freeze–thaw stress [ | Absent |
| 28 | Inter-alpha-trypsin inhibitor heavy chain 1 precursor | 101.2 | Serine protease inhibitor | Absent |
| 29 | keratin 25, type I like | 49.3 | Intermediate filament | Absent |
| 30 | Bovine hemoglobin chain C | 15 | Metalloprotein | Absent |
| 31 | Hemoglobin, beta | 16 | Globin protein | Absent |
| 32 | Apolipoprotein N | 28.5 | Lipoprotein | Absent |
| 34 | Collagen, type III, alpha 1 | 137.1 | Fibrous scleroprotein | Absent |
| 35 | Immunoglobulin light chain | 10.4 | Polypeptide | Absent |
| 36 | Alpha-2-macroglobulin variant 1 | 115.1 | Plasma protein/proteinase inhibitor and anti-apoptotic protein [ | Absent |
| 37 | Alpha-2-macroglobulin variant 4 | 42.3 | Plasma protein/proteinase inhibitor and anti-apoptotic protein [ | Absent |
| 38 | Kininogen isoform X2 | 44.4 | Polypeptide | Absent |
| 39 | Protein dimmed | 39.4 | Helix-loop-helix protein | Absent |
| 40 | Primary amine oxidase | 81.7 | Copper containing enzymes/biological regulator of cell growth and differentiationand is also involved in apoptosis regulation by altering membranes [ | Absent |
| 41 | Actin, alpha 2, smooth muscle, aorta | 39.3 | Globular protein | Absent |
| 42 | Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like | 81.6 | Ligase | Absent |